Biolife Solutions Stock Buy Hold or Sell Recommendation
BLFS Stock | USD 18.46 0.36 1.99% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding BioLife Solutions is 'Hold'. Macroaxis provides BioLife Solutions buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BLFS positions. The advice algorithm takes into account all of BioLife Solutions' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting BioLife Solutions' buy or sell advice are summarized below:
Real Value 21.09 | Target Price 24.43 | Hype Value 18.38 | Market Value 18.46 | Naive Value 19.18 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell BioLife Solutions given historical horizon and risk tolerance towards BioLife Solutions. When Macroaxis issues a 'buy' or 'sell' recommendation for BioLife Solutions, the advice is generated through an automated system that utilizes algorithms and statistical models.
BioLife |
Execute BioLife Solutions Buy or Sell Advice
The BioLife recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BioLife Solutions. Macroaxis does not own or have any residual interests in BioLife Solutions or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioLife Solutions' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Hold
Market Performance | Modest | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
BioLife Solutions Trading Alerts and Improvement Suggestions
The company reported the previous year's revenue of 143.27 M. Net Loss for the year was (66.43 M) with profit before overhead, payroll, taxes, and interest of 54.07 M. | |
BioLife Solutions currently holds about 46.55 M in cash with (12.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.09. | |
BioLife Solutions has a frail financial position based on the latest SEC disclosures | |
Over 96.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from investing.com: Biolife Solutions CFO sells shares worth over 9k |
BioLife Solutions Returns Distribution Density
The distribution of BioLife Solutions' historical returns is an attempt to chart the uncertainty of BioLife Solutions' future price movements. The chart of the probability distribution of BioLife Solutions daily returns describes the distribution of returns around its average expected value. We use BioLife Solutions price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BioLife Solutions returns is essential to provide solid investment advice for BioLife Solutions.
Mean Return | 0.28 | Value At Risk | -3.94 | Potential Upside | 5.71 | Standard Deviation | 2.83 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BioLife Solutions historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BioLife Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as BioLife Solutions is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioLife Solutions backward and forwards among themselves. BioLife Solutions' institutional investor refers to the entity that pools money to purchase BioLife Solutions' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Amvescap Plc. | 2023-12-31 | 1.2 M | Geneva Capital Management | 2023-12-31 | 874.5 K | Royce & Associates, Lp | 2023-12-31 | 871.6 K | Geode Capital Management, Llc | 2023-12-31 | 757.2 K | Gagnon Securities Llc | 2023-12-31 | 627.5 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 618.1 K | Citadel Advisors Llc | 2023-09-30 | 609 K | Portolan Capital Management, Llc | 2023-12-31 | 521.9 K | New York State Common Retirement Fund | 2023-12-31 | 420.4 K | Casdin Capital, Llc | 2023-12-31 | 8.7 M | Blackrock Inc | 2023-12-31 | 5.4 M |
BioLife Solutions Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (24.2M) | 84.0M | (20.6M) | (50.4M) | 16.0M | 16.8M | |
Free Cash Flow | 538K | 1.9M | (13.2M) | (18.9M) | (18.9M) | (17.9M) | |
Depreciation | 1.8M | 5.1M | 12.9M | 16.5M | 12.3M | 12.9M | |
Other Non Cash Items | 4.0M | (2.1M) | (364K) | 109.7M | 8.6M | 9.0M | |
Capital Expenditures | 675K | 4.6M | 8.4M | 10.4M | 6.4M | 6.7M | |
Net Income | (1.7M) | 2.7M | (7.6M) | (139.8M) | (66.4M) | (63.1M) | |
End Period Cash Flow | 6.4M | 90.5M | 69.9M | 19.5M | 35.4M | 37.2M | |
Change To Inventory | (3.8M) | (629K) | 114K | (6.6M) | (8.6M) | (8.1M) | |
Change Receivables | 172.3K | (2.0M) | (290K) | (1.8M) | (1.6M) | (1.5M) | |
Net Borrowings | 979.8K | (56K) | 984K | (2.9M) | (2.6M) | (2.5M) | |
Change To Netincome | 15.0M | (1.2M) | (9.0M) | 114.8M | 132.0M | 138.6M | |
Investments | 1M | (23.7M) | (12.6M) | (58.1M) | (1.0M) | (1.1M) |
BioLife Solutions Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioLife Solutions or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioLife Solutions' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioLife stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.09 | |
β | Beta against NYSE Composite | 2.92 | |
σ | Overall volatility | 2.87 | |
Ir | Information ratio | 0.05 |
BioLife Solutions Volatility Alert
BioLife Solutions currently demonstrates below-average downside deviation. It has Information Ratio of 0.05 and Jensen Alpha of -0.09. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BioLife Solutions' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BioLife Solutions' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.BioLife Solutions Fundamentals Vs Peers
Comparing BioLife Solutions' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioLife Solutions' direct or indirect competition across all of the common fundamentals between BioLife Solutions and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioLife Solutions or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BioLife Solutions' fundamental indicators could also be used in its relative valuation, which is a method of valuing BioLife Solutions by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare BioLife Solutions to competition |
Fundamentals | BioLife Solutions | Peer Average |
Return On Equity | -0.19 | -0.31 |
Return On Asset | -0.0833 | -0.14 |
Profit Margin | (0.46) % | (1.27) % |
Operating Margin | (0.41) % | (5.51) % |
Current Valuation | 810.93 M | 16.62 B |
Shares Outstanding | 45.3 M | 571.82 M |
Shares Owned By Insiders | 3.57 % | 10.09 % |
Shares Owned By Institutions | 96.43 % | 39.21 % |
Number Of Shares Shorted | 3.03 M | 4.71 M |
Price To Earning | 173.59 X | 28.72 X |
Price To Book | 2.43 X | 9.51 X |
Price To Sales | 5.80 X | 11.42 X |
Revenue | 143.27 M | 9.43 B |
Gross Profit | 54.07 M | 27.38 B |
EBITDA | (45.24 M) | 3.9 B |
Net Income | (66.43 M) | 570.98 M |
Cash And Equivalents | 46.55 M | 2.7 B |
Cash Per Share | 1.09 X | 5.01 X |
Total Debt | 42.69 M | 5.32 B |
Debt To Equity | 0.06 % | 48.70 % |
Current Ratio | 3.55 X | 2.16 X |
Book Value Per Share | 7.48 X | 1.93 K |
Cash Flow From Operations | (12.5 M) | 971.22 M |
Short Ratio | 10.51 X | 4.00 X |
Earnings Per Share | (1.52) X | 3.12 X |
Price To Earnings To Growth | 63.20 X | 4.89 X |
Target Price | 23.29 | |
Number Of Employees | 409 | 18.84 K |
Beta | 1.66 | -0.15 |
Market Capitalization | 830.35 M | 19.03 B |
Total Asset | 412.71 M | 29.47 B |
Retained Earnings | (313.34 M) | 9.33 B |
Working Capital | 78.43 M | 1.48 B |
Note: Disposition of 520 shares by Troy Wichterman of BioLife Solutions at 17.83 subject to Rule 16b-3 [view details]
BioLife Solutions Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioLife . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BioLife Solutions Buy or Sell Advice
When is the right time to buy or sell BioLife Solutions? Buying financial instruments such as BioLife Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 20.4M | 23.8M | 24.6M | 25.8M | Total Assets | 552.6M | 450.2M | 412.7M | 433.3M |
Use Investing Ideas to Build Portfolios
In addition to having BioLife Solutions in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Robots And Drones Thematic Idea Now
Robots And Drones
Large technology companies that are involved in development and manufacturing of drones, robots, or robotic equipment across mechanical engineering, electrical engineering, mathematics and computer science fields. Drones and robotics are projected to significantly grow in demand in the next 5 years. The Robots And Drones theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Robots And Drones Theme or any other thematic opportunities.
View All Next | Launch |
Check out BioLife Solutions Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.Note that the BioLife Solutions information on this page should be used as a complementary analysis to other BioLife Solutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for BioLife Stock analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is BioLife Solutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLife Solutions. If investors know BioLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.4 | Earnings Share (1.52) | Revenue Per Share 3.277 | Quarterly Revenue Growth (0.26) | Return On Assets (0.08) |
The market value of BioLife Solutions is measured differently than its book value, which is the value of BioLife that is recorded on the company's balance sheet. Investors also form their own opinion of BioLife Solutions' value that differs from its market value or its book value, called intrinsic value, which is BioLife Solutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLife Solutions' market value can be influenced by many factors that don't directly affect BioLife Solutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioLife Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.